ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Enhancing Oncology Trials With Clinical Platform Solutions

  This example involves a top 10 pharmaceutical company and explores how they were able to improve oncology trial efficiency, safety, patient experience, and more using a platform approach.

• Modern Post-Market Trials Driven By RWD – Is Your EDC Ready?

  Explore the transformative role of real-world data (RWD) and advanced Electronic Data Capture (EDC) systems in post-market research, marking a departure from traditional Phase IV trials.

• 7 eCOA Design Recommendations: Insights From Sites And CRAs

  Signant joined a group of C-Path members including other eCOA solution providers, sponsors, and regulators for a GBTI project that revealed several opportunities to improve eCOA usability and flexibility.

• Cytokine Release Syndrome Monitoring

  Here we introduce an innovative risk-monitoring solution aimed at mitigating Cytokine Release Syndrome (CRS), a critical complication in immunotherapy that often leads to prolonged hospitalization.

• Reflexion Counts On Medrio To Launch First Studies

  Learn how a therapeutic oncology company was able to take advantage of an EDC system, establish a ePRO assessments collections platform, and receive guidance on data collection devices.

• How FAIR Data Principles Deliver Clinical Success

  Prioritize data management that adheres to FAIR principles — findable, accessible, interoperable, and reusable — to gain operational insights that enable quick decisions and ensure participant well-being.

• Taking Advantage Of EMA CTR For eCOA Studies In EU

  Discover how sponsors can save time and effort by applying for clinical trial authorization once across the EU using the Clinical Trials Information System (CTIS).

• CRO Uses CRIO eSource To Double Monitoring Productivity

  Examine the transformative impact of eSource technology on monitoring productivity during a global Phase 3 trial conducted by a Contract Research Organization (CRO) amid the COVID-19 pandemic.

• How Paper And Electronic Source Data Meet ALCOA-C Principles

  According to the Food and Drug Administration (FDA), data should meet certain fundamental elements of quality. If these best practices for source documentation aren’t followed, there is no valid evidence the test article is safe and effective. 

• Why The Future Looks Bright For eCOA In Clinical Trials

  Unearth the ways electronic clinical outcome assessment technology is revolutionizing data collection, improving patient experiences, and enhancing trial outcomes.